CA2137088A1 - Methode d'hemodialyse et liquides pour hemodialyse qui contiennent de l'acide chlorhydrique - Google Patents

Methode d'hemodialyse et liquides pour hemodialyse qui contiennent de l'acide chlorhydrique

Info

Publication number: CA2137088A1
Authority: CA; Canada
Prior art keywords: acid; meq; alkalizer; fluid; concentrate
Prior art date: 1992-06-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002137088A

Other languages

English (en)

Inventor

Louis C. Cosentino

Walter B. Jansen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Minntech Corp

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-03

Filing date

1993-05-06

Publication date

1993-12-09

1993-05-06 Application filed by Individual filed Critical Individual

1993-12-09 Publication of CA2137088A1 publication Critical patent/CA2137088A1/fr

Status Abandoned legal-status Critical Current

Links

VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims description 38
238000001631 haemodialysis Methods 0.000 title claims description 31
230000000322 hemodialysis Effects 0.000 title claims description 31
238000000034 method Methods 0.000 title claims description 5
239000007788 liquid Substances 0.000 title description 2
239000012530 fluid Substances 0.000 claims abstract description 72
239000002253 acid Substances 0.000 claims abstract description 53
239000012141 concentrate Substances 0.000 claims abstract description 53
239000000872 buffer Substances 0.000 claims abstract description 39
239000008280 blood Substances 0.000 claims abstract description 32
210000004369 blood Anatomy 0.000 claims abstract description 32
239000012528 membrane Substances 0.000 claims abstract description 30
238000010790 dilution Methods 0.000 claims abstract description 23
239000012895 dilution Substances 0.000 claims abstract description 23
238000000502 dialysis Methods 0.000 claims abstract description 19
239000003085 diluting agent Substances 0.000 claims abstract description 19
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 16
FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 17
229910001415 sodium ion Inorganic materials 0.000 claims description 17
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
239000008121 dextrose Substances 0.000 claims description 15
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 14
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 9
150000002500 ions Chemical class 0.000 claims description 9
239000012510 hollow fiber Substances 0.000 claims description 8
239000000203 mixture Substances 0.000 claims description 6
235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
229910001424 calcium ion Inorganic materials 0.000 claims description 4
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 4
229910001425 magnesium ion Inorganic materials 0.000 claims description 4
NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
229910001414 potassium ion Inorganic materials 0.000 claims description 3
239000000463 material Substances 0.000 abstract description 20
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 16
210000003734 kidney Anatomy 0.000 abstract description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
239000011780 sodium chloride Substances 0.000 description 10
238000002156 mixing Methods 0.000 description 6
239000000243 solution Substances 0.000 description 6
239000000385 dialysis solution Substances 0.000 description 5
208000024891 symptom Diseases 0.000 description 5
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
239000002207 metabolite Substances 0.000 description 4
-1 polyimidazole Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
239000000047 product Substances 0.000 description 4
239000008213 purified water Substances 0.000 description 4
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
239000007853 buffer solution Substances 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
230000004060 metabolic process Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
239000001632 sodium acetate Substances 0.000 description 3
235000017281 sodium acetate Nutrition 0.000 description 3
239000000126 substance Substances 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
208000001647 Renal Insufficiency Diseases 0.000 description 2
241000220317 Rosa Species 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000003146 anticoagulant agent Substances 0.000 description 2
229940127219 anticoagulant drug Drugs 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000000470 constituent Substances 0.000 description 2
238000010586 diagram Methods 0.000 description 2
239000003792 electrolyte Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
208000017169 kidney disease Diseases 0.000 description 2
201000006370 kidney failure Diseases 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
238000011282 treatment Methods 0.000 description 2
UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical compound C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
208000001953 Hypotension Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000011260 aqueous acid Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000000701 coagulant Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
239000003959 coumarin anticoagulant Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
230000036543 hypotension Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
239000006166 lysate Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229940094443 oxytocics prostaglandins Drugs 0.000 description 1
238000010979 pH adjustment Methods 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920002492 poly(sulfone) Polymers 0.000 description 1
229920002239 polyacrylonitrile Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
150000003180 prostaglandins Chemical class 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
210000005227 renal system Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
241000894007 species Species 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000003860 storage Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
239000002699 waste material Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor

Landscapes

Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Vascular Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
External Artificial Organs (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002137088A 1992-06-03 1993-05-06 Methode d'hemodialyse et liquides pour hemodialyse qui contiennent de l'acide chlorhydrique Abandoned CA2137088A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US89256492A	1992-06-03	1992-06-03
US07/892,564		1992-06-03

Publications (1)

Publication Number	Publication Date
CA2137088A1 true CA2137088A1 (fr)	1993-12-09

Family

ID=25400143

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002137088A Abandoned CA2137088A1 (fr)	1992-06-03	1993-05-06	Methode d'hemodialyse et liquides pour hemodialyse qui contiennent de l'acide chlorhydrique

Country Status (6)

Country	Link
EP (1)	EP0647130A1 (fr)
JP (1)	JPH07504591A (fr)
AU (1)	AU4239593A (fr)
CA (1)	CA2137088A1 (fr)
HU (1)	HUT68062A (fr)
WO (1)	WO1993024108A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EG24303A (en) *	1998-10-20	2009-01-12	Advanced Renal Technologies	Buffered compositions for dialysis
US7670491B2 (en)	1998-10-20	2010-03-02	Advanced Renal Technologies	Buffered compositions for dialysis
US7186420B2 (en)	1999-04-26	2007-03-06	Edwards Lifesciences Corporation	Multi-part substitution infusion fluids and matching anticoagulants
WO2000064456A2 (fr) *	1999-04-26	2000-11-02	Pe Chou Chang	Liquide d'infusion de substitution et solution anticoagulante a base de citrate
US8105258B2 (en)	1999-04-26	2012-01-31	Baxter International Inc.	Citrate anticoagulation system for extracorporeal blood treatments
DE19955578C1 (de) *	1999-11-18	2001-09-06	Fresenius Medical Care De Gmbh	Mehrkammerbehälter, mit Glucosekonzentratkompartiment und Salzsäurekonzentratkompartiment
US7445801B2 (en)	2002-06-07	2008-11-04	Baxter International Inc.	Stable bicarbonate-based solution in a single container
CN100457203C (zh) *	2006-01-10	2009-02-04	赵滨宇	血液透析循环装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4399036A (en) *	1979-06-14	1983-08-16	Diachem, Inc.	Proportioning system for bicarbonate dialysate
US4366881A (en) *	1980-12-11	1983-01-04	J. I. Case Company	Flip-up control console

1993
- 1993-05-06 CA CA002137088A patent/CA2137088A1/fr not_active Abandoned
- 1993-05-06 WO PCT/US1993/004351 patent/WO1993024108A1/fr not_active Ceased
- 1993-05-06 AU AU42395/93A patent/AU4239593A/en not_active Abandoned
- 1993-05-06 JP JP6500560A patent/JPH07504591A/ja active Pending
- 1993-05-06 EP EP93911157A patent/EP0647130A1/fr not_active Withdrawn
- 1993-05-06 HU HU9403380A patent/HUT68062A/hu unknown

Also Published As

Publication number	Publication date
WO1993024108A1 (fr)	1993-12-09
HU9403380D0 (en)	1995-02-28
EP0647130A1 (fr)	1995-04-12
JPH07504591A (ja)	1995-05-25
AU4239593A (en)	1993-12-30
HUT68062A (en)	1995-05-29

Publication	Publication Date	Title
JP2948315B2 (ja)	1999-09-13	透析物ペレットを有する透析物生成システム
EP0980685B1 (fr)	2006-01-25	Utilisation d'un liquide pour la fabrication d'un liquide de dialyse pour la dialyse péritonéale continue avec recirculation
US4336881A (en)	1982-06-29	Aqueous acid concentrate for hemodialysis dialysate
US6841172B1 (en)	2005-01-11	Method for iron delivery to a patient by transfer from dialysate
CA2140521C (fr)	1999-11-16	Appareil et methode visant a prevenir l'hypotension chez les dialyses
US4326955A (en)	1982-04-27	Hemodialysis with sodium bicarbonate dialysate prepared in plural stages
EP0571610B1 (fr)	1996-05-29	Appareil et systeme connecteurs
EP0399572B1 (fr)	1995-02-08	Dispositif pour la séparation des protéines du plasma sanguin
US4308255A (en)	1981-12-29	Balanced oncotic pressure fluid
US7300636B2 (en)	2007-11-27	Method for producing a dialysate solution
Blumenkrantz et al.	1979	Applications of the Redy® sorbent system to hemodialysis and peritoneal dialysis
US10322221B2 (en)	2019-06-18	Removal of carbon dioxide via dialysis
JP2009528897A (ja)	2009-08-13	着用可能な腎臓
Hoenich et al.	2005	The importance of water quality and haemodialysis fluid composition
ES2149793T3 (es)	2000-11-16	Procedimiento para la preparacion de liquido dializador bicarbonatado para la hemodialisis.
CA2137088A1 (fr)	1993-12-09	Methode d'hemodialyse et liquides pour hemodialyse qui contiennent de l'acide chlorhydrique
JP2000072658A (ja)	2000-03-07	腹膜透析液および腹膜透析法
CA1166966A (fr)	1984-05-08	Obtention de dialysat contenant du bicarbonate
EP0457960A2 (fr)	1991-11-27	Dialysats à haute concentration d'acide
Shaldon et al.	1978	Sorbent Regeneration of Ultrafiltrate as a Long‐Term Treatment of End‐Stage Renal Failure
CA2365517A1 (fr)	2002-06-20	Solutions concentrees steriles sans bicarbonate pour dialyse
CA1327756C (fr)	1994-03-15	Methode de fabrication de solutions steriles, apyrogenes
EP3452136B1 (fr)	2024-03-27	Concentré pour dialyse
Friedman et al.	1980	Dialysate delivery: Historical, theoretical, and practical aspect.
Man et al.	1995	Dialysis Equipment

Legal Events

Date	Code	Title	Description
1994-11-30	EEER	Examination request
1997-05-06	FZDE	Discontinued